{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "Y",
          "alt": "C",
          "position": "1699"
        },
        "variant_string_id": "LRRK2 Y1699C"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in LRRK2 are a prevalent cause of autosomal dominant PD, affecting GTPase activity and protein interactions.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines that LRRK2 mutations disrupt GTPase activity and dimerization, which are central to the disease mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Functional assays included GTPase activity measurements and protein interaction studies.",
          "judgment": "Yes",
          "reasoning": "The assays directly assess known mechanisms of PD caused by LRRK2 mutations, making them relevant."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Controls included wild-type and other mutants (e.g., R1441C).",
          "judgment": "Yes",
          "reasoning": "Wild-type and pathogenic controls were used, ensuring valid comparison."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Y1699C showed decreased GTPase activity and altered dimerization.",
          "judgment": "PS3_moderate",
          "reasoning": "The mutation clearly impairs function, supporting pathogenicity but not meeting the highest criteria."
        }
      ]
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "R",
          "alt": "C",
          "position": "1441"
        },
        "variant_string_id": "LRRK2 R1441C"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "R1441C affects GTPase activity and dimerization.",
          "judgment": "Yes",
          "reasoning": "The mutation's effects align with known mechanisms of PD."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Assays measured GTPase activity and protein interactions.",
          "judgment": "Yes",
          "reasoning": "Relevant to assessing PD-causing mutations."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Controls included wild-type and other mutants.",
          "judgment": "Yes",
          "reasoning": "Valid comparison using appropriate controls."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "R1441C showed decreased GTPase activity and weakened dimerization.",
          "judgment": "PS3_moderate",
          "reasoning": "Significant functional impairment supports pathogenicity."
        }
      ]
    }
  ]
}